Jamie Rijmers

In October 2021, I joined the group of Alfred Schinkel as a PhD student. My project will focus on the effect of ABC and OATP transporters and drug-metabolizing enzymes on in vivo drug efficacy. Both pharmacokinetics and pharmacodynamics of anti-cancer drugs will be evaluated using in vivo mouse models. The obtained insights may help to improve the pharmacotherapy of cancer, but might also be applicable to other diseases.